Sign in

CIK 0001711754

  • Non-accelerated filer
  • Smaller reporting company

Inmune Bio, Inc.

Sign in to watch
Ticker
INMB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
475205835
Phone
+1 858-964-3720
Business address
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, FL, 33432
  1. 4 Open-market buy President & CEO bought 2,000 shares at an average $5.99 ($11,987)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market buy President & CEO bought 2,000 shares at an average $7.03 ($14,058)
  4. 4 Open-market buy 10% owner bought 10,000 shares at $6.00 ($60,000)
  5. 4 Open-market buy Director bought 10,000 shares at $6.00 ($60,000)
  6. 4 Open-market buy CFO, Treasurer & Secretary bought 10,000 shares at $6.00 ($60,000)
  7. 4 Open-market buy President & CEO bought 10,000 shares at $6.00 ($60,000)
  8. 4/A Open-market buy President & CEO bought 11,100 shares at $10.75 ($119,325)
  9. 4/A Open-market buy CFO, Treasurer & Secretary bought 5,000 shares at $10.71 ($53,550)
  10. 4 Open-market buy 10% owner bought 61,667 shares at $9.00 ($555,003)
  11. 3 Insider Initial Statement of Ownership
  12. 4/A Open-market buy President & CEO bought 11,100 shares at $9.00 ($99,900)
  13. 4 Open-market buy CFO, Treasurer & Secretary bought 5,000 shares at $9.00 ($45,000)
  14. 4 Open-market buy Chairman bought 11,100 shares at $9.90 ($109,890)
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 7 of 8 · 142 filings